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Patent ductus arteriosus (PDA) is common congenital heart disease which may require
treatment as transcatheter percutaneous device closure (PDA device closure) or surgical
ligation in symptomatic full-term patients. Surgical ligation is an invasive procedure and
has more complications especially in the neonates. Problems in PDA device closure are
difficult vascular access, manipulation of catheters and sheath, residual shunts, residual
obstruction of major arteries etc and these complications increase in low birth weight
babies, but it is a less invasive procedure and has fewer complications than surgery, so
should be tried in low birth weight patients also. We are presenting a case of 3 kg infant
with large PDA (8 mm) presented with failure to thrive, lower respiratory tract infection
and heart failure. He successfully underwent PDA device closure with 10  12 mm Cocoon
PDA device. To the best of our knowledge, this is the first case of the use of such a large
device in a 3 kg child with good results.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
Patent ductus arteriosus (PDA) is one of the common
congenital acyanotic heart disease with incidence reported to
be 1 in 2000 full-term births.1,2 The clinical presentation, its5 (mobile).
.com (D. Ware).
ociety of India. All rightstiming vary with size of PDA. Patient generally presents with
signs and symptoms of cardiac failure due to left ventricular
volume overload. For symptomatic full-term patients, trans-
catheter percutaneous PDA device closure (PDA device
closure) and open surgical ligation aremodalities to treat PDA.reserved.
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except if PDA is window type (type B) PDA, distorted ductal
anatomy (e.g. aneurysm or endarteritis).3 Common problems
in PDA device closure are low weight for age, vascular access,
residual shunts, manipulation of catheters and sheath etc.4
We are presenting a case of one-year old male child with
8 mm PDA, significantly low weight for age (3 kg) and pre-
sentation of failure to thrive. He underwent successful PDA
device closure.Fig. 2 e Check shoot of PDA in lateral view.2. Case
One-year old male infant was referred to our hospital with
complaints of suck rest cycles, recurrent cold, cough, fever,
increased precordial activity and failure to gain weight since
birth. His weight was 3.0 kg (less than 3rd percentile of weight
for age,WHO chart).When examined patient had pulse of 124/
min, BP of 96/62 mm of Hg in right upper limb. On ausculta-
tion, he had grade IV/VI continuous murmur in left second
intercostal space. 2D transthoracic echocardiography (2D TTE)
was done which showed 6 mm of PDA (Fig. 1) with left to right
shunt. Systolic and diastolic gradients across PDAwere 50 and
15 mm of Hg respectively.
Surgical closure was the first option to be considered but
since the child was very low birth weight, so he was a high risk
candidate for surgery. On 2D TTE, PDA had sufficiently long
length with good ampulla which would have accommodated
wholedevicewithoutmuchprotrusion intoaorticorpulmonary
arteries preventing their obstruction by the device. So, it was
then decided to attempt PDA device closure percutaneously.
Patient was taken up for procedure under general anes-
thesia. Under all aseptic precautions, right femoral artery ac-
cess was taken with 4F sheath and right femoral vein access
was taken with 5F sheath. 4F pigtail catheter then passed
through right femoral artery and kept in aortic arch. Shoot
was taken in left lateral view with pressure injector which
showed PDA of 8 mm (Fig. 2) with left to right shunt.Fig. 1 e Preprocedure 2D Echo.It was then decided to use PDA device of 10  12 mm to
occlude this PDA. It is worthwhile noting that Amplatzer
ductal occluder II (ADO II, St Jude Medical Inc., Minnesota,
USA), made for low weight patients, was not an option as it is
available in sizes to occlude PDAs of 5.5 mm. 5F multipurpose
catheter A1 was then passed through right femoral vein up to
main pulmonary artery and then through PDA into descend-
ing aorta. Catheter was exchanged with 0.035 inch 260 cm
super stiff wire. 7F delivery system was placed in the
descending aorta. A 10  12 mm Cocoon PDA device (Vascular
Innovations Co. Ltd, Thailand) was then passed through the
delivery catheter into the descending aorta and pulled back
into the ampulla and the device was positioned across the
ductus by withdrawing the sheath as usual. A check aorto-
gramwas taken in lateral viewwhich showed device in proper
position with no obstruction in the aorta. There was no flow
across the device into the pulmonary artery (Fig. 3). 2D TTE
was carried out in the catheterization laboratory to ensure
that there was no pulmonary arterial obstruction. PDA device
was then released from delivery system. Again check aorto-
gram taken after 10 min confirmed device in position with no
residual shunt. The pressure recording taken during a pull-
back from ascending to descending aorta showed no gradient
across the aorta at the level of the device.
Post procedure 2D TTE was done which showed device in
situ with no flow across PDA, no gradient across left pulmo-
nary artery (LPA) and aorta at the site of PDA device. Patient
was given weight adjusted dose of aspirin.3. Discussion
Large PDA in pediatric patient causes failure to gain weight
which poses risk for intervention and surgery. PDA device
Fig. 3 e Check shoot after PDA device released in lateral
view.
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tions in full-term and normal weight children. The specific
problems faced during PDA device closure in low weight for
age pediatric patients are difficult vascular access, catheter
manipulation, protrusion of device in aorta and pulmonary
artery causing flow obstruction, device embolization etc.
Therefore, surgical PDA ligation is generally preferred over
device closure, in these patients. However, if the PDA is suf-
ficiently long to accommodate the device as in our case,
chances of aortic and pulmonary obstruction as well as that of
embolization are very low. Food And Drug Administration of
USA has approved Amplatzer duct occluder (ADO) for pedi-
atric patients with weight 6 kg.5
The most important factors determining the success of
PDA device closure are the weight of the baby, ductal size and
anatomy, and the availability of suitable hardware.6 Because
of less complications, comparable success rates, less inva-
siveness, availability of suitable devices as compared to sur-
gical ligation, PDA device closure is rapidly becoming a
popular method in low weight for age pediatric patients with
PDA which has favorable anatomy for device closure as in our
case.4. Conclusion
Low weight for age pediatric patients of significant PDA are
candidates for PDA device closure technique. Surgical closure
of PDA is generally the chosen option because of being less
technically demanding procedure as compared to PDA device
closure but it is more invasive. Though a technically
demanding procedure but PDA device closure is a relatively
safer procedure and also has good success rate. In case of
favorable anatomy like long length and no aneurysm or
constriction in PDA, device closure can definitely be
attempted. To the best of our knowledge, this is the first case
of the use of such a large device in a 3 kg child with good
results.Conflicts of interest
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